Having trouble accessing articles? Reset your cache.

A tumor-targeted Bavencio conjugate with enhanced antitumor efficacy

DISEASE CATEGORY: Cancer

INDICATION: Melanoma

Coupling a pegylated α-MSH analog to anti-PD-1 antibodies could enhance antitumor immunity. α-MSH is the ligand for

Read the full 202 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE